John Steele, MD
Adult Reconstructive Orthopaedic Surgery · Towson, MDNPI 1881057131
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $33,838 of the $51,790 with a category attached, or 65.3%. Medical Device Business Services, Inc. accounts for 62.3% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $31,494, 2.3 times the $13,610 reported in 2022.
Across 70 payments — averaging $739.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$32K
- Smith+Nephew$12K
- Depuy Synthes Products, Inc.$6K
- Johnson & Johnson$788
- Stryker$558
- C. R. Bard, Inc. & Subsidiaries$164
- plus $292 from 4 others
What the payments were for
- Consulting fees$33,83865%
- Travel & lodging$2,9186%
- Food & beverage$3,0356%
- Education$12,00023%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 35 | $32,257 |
| Smith+Nephew | 3 | $12,088 |
| Depuy Synthes Products, Inc. | 3 | $5,644 |
| Johnson & Johnson(2 entities) | 12 | $788 |
| Stryker | 7 | $558 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $164 |
| Orthalign Inc | 1 | $143 |
| Native Surgical, LLC | 3 | $80 |
| Pacira Pharmaceuticals Incorporated | 3 | $52 |
| Zimmer Biomet | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Velys$1,572
- ACTIS$1,007
- ATTUNE$413
- TRIATHLON$173
- ORTHALIGN PLUS$143
- ARISTA AH FLEXITIP$142
- MAKO$125
How this compares
$51,790 in reported general payments places this provider in the 80th percentile of 33 adult reconstructive orthopaedic surgery providers in Maryland.
See all adult reconstructive orthopaedic surgery providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 64 | $1,691 |
| Methylprednisolone | 127 | $841 |
| Mupirocin | 111 | $672 |
| Meloxicam | 193 | $632 |
| Doxycycline Hyclate | 13 | $183 |
| Amoxicillin | 97 | $141 |
| Gabapentin | 26 | $64 |
| Clindamycin Hcl | 14 | $33 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Towson
- Michael MontBaltimore$10.9M
- Randal LewisChevy Chase$2.6M
- Sridhar DurbhakulaBethesda$766K
- Pasquale PetreraSalisbury$137K
- Pablo WagnerBaltimore$118K
- James NaceBaltimore$102K
- Ryan ScullyChevy Chase$43K
- David SilberWestminster$37K
- Mark HasenauerBaltimore$35K
- James MacdonaldAnnapolis$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.